177 related articles for article (PubMed ID: 17325347)
41. Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine viral diarrhea virus.
Wang L; Sunyer JO; Bello LJ
J Virol; 2004 Feb; 78(4):1616-22. PubMed ID: 14747527
[TBL] [Abstract][Full Text] [Related]
42. Packaged replicons of bovine viral diarrhea virus are capable of inducing a protective immune response.
Reimann I; Semmler I; Beer M
Virology; 2007 Sep; 366(2):377-86. PubMed ID: 17544049
[TBL] [Abstract][Full Text] [Related]
43. Microparticle-mediated RNA immunization against bovine viral diarrhea virus.
Vassilev VB; Gil LH; Donis RO
Vaccine; 2001 Feb; 19(15-16):2012-9. PubMed ID: 11228372
[TBL] [Abstract][Full Text] [Related]
44. The Occurrence of a Commercial N
Wernike K; Michelitsch A; Aebischer A; Schaarschmidt U; Konrath A; Nieper H; Sehl J; Teifke JP; Beer M
Viruses; 2018 May; 10(5):. PubMed ID: 29783722
[TBL] [Abstract][Full Text] [Related]
45. Bovine viral diarrhea virus with deletions in the 5'-nontranslated region: reduction of replication in calves and induction of protective immunity.
Makoschey B; Becher P; Janssen MG; Orlich M; Thiel HJ; Lütticken D
Vaccine; 2004 Sep; 22(25-26):3285-94. PubMed ID: 15308351
[TBL] [Abstract][Full Text] [Related]
46. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I.
Beer M; Hehnen HR; Wolfmeyer A; Poll G; Kaaden OR; Wolf G
Vet Microbiol; 2000 Nov; 77(1-2):195-208. PubMed ID: 11042413
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the onset of protection induced by a modified-live virus vaccine in calves challenge inoculated with type 1b bovine viral diarrhea virus.
Palomares RA; Givens MD; Wright JC; Walz PH; Brock KV
Am J Vet Res; 2012 Apr; 73(4):567-74. PubMed ID: 22452506
[TBL] [Abstract][Full Text] [Related]
48. Mosaic Bovine Viral Diarrhea Virus Antigens Elicit Cross-Protective Immunity in Calves.
Sangewar N; Hassan W; Lokhandwala S; Bray J; Reith R; Markland M; Sang H; Yao J; Fritz B; Waghela SD; Abdelsalam KW; Chase CCL; Mwangi W
Front Immunol; 2020; 11():589537. PubMed ID: 33281819
[TBL] [Abstract][Full Text] [Related]
49. Protective effect of an ISCOM bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes.
Carlsson U; Alenius S; Sundquist B
Vaccine; 1991 Aug; 9(8):577-80. PubMed ID: 1663302
[TBL] [Abstract][Full Text] [Related]
50. Vaccination of cattle against bovine viral diarrhea virus.
Newcomer BW; Chamorro MF; Walz PH
Vet Microbiol; 2017 Jul; 206():78-83. PubMed ID: 28400145
[TBL] [Abstract][Full Text] [Related]
51. Interferon lambda protects cattle against bovine viral diarrhea virus infection.
Quintana ME; Cardoso NP; Pereyra R; Barone LJ; Barrionuevo FM; Mansilla FC; Turco CS; Capozzo AV
Vet Immunol Immunopathol; 2020 Dec; 230():110145. PubMed ID: 33160262
[TBL] [Abstract][Full Text] [Related]
52. Recombinant E
Wang S; Yang G; Nie J; Yang R; Du M; Su J; Wang J; Wang J; Zhu Y
Vaccine; 2020 May; 38(22):3881-3891. PubMed ID: 32280039
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
[TBL] [Abstract][Full Text] [Related]
54. Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine.
Brownlie J; Clarke MC; Hooper LB; Bell GD
Vet Rec; 1995 Jul; 137(3):58-62. PubMed ID: 8533232
[TBL] [Abstract][Full Text] [Related]
55. Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.
Couvreur B; Letellier C; Olivier F; Dehan P; Elouahabi A; Vandenbranden M; Ruysschaert JM; Hamers C; Pastoret PP; Kerkhofs P
Vet Res; 2007; 38(6):819-34. PubMed ID: 17727807
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of bovine viral diarrhea vaccine used in Japan against bovine viral diarrhea virus type 2 strain 890.
Shimazaki T; Nakamura S; Taguchi K; Inoue Y
J Vet Med Sci; 2003 Feb; 65(2):263-6. PubMed ID: 12655125
[TBL] [Abstract][Full Text] [Related]
58. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
[TBL] [Abstract][Full Text] [Related]
59. Duration of immunity of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV, and BRSV in experimentally infected calves.
Peters AR; Thevasagayam SJ; Wiseman A; Salt JS
Prev Vet Med; 2004 Dec; 66(1-4):63-77. PubMed ID: 15579335
[TBL] [Abstract][Full Text] [Related]
60. Priming with DNA encoding E2 and boosting with E2 protein formulated with CpG oligodeoxynucleotides induces strong immune responses and protection from Bovine viral diarrhea virus in cattle.
Liang R; van den Hurk JV; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2006 Oct; 87(Pt 10):2971-2982. PubMed ID: 16963756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
